Acetylation of Sox2 induces its nuclear export in embryonic stem cells

Stem Cells

Volumn 27, Issue 9, 2009, Pages 2175-2184

  Baltus, Gretchen A ^a   Kowalski, Michael P ^a   Zhai, Huili ^a   Tutter, Antonin V ^a   Quinn, Douglas ^a   Wall, Daniel ^a   Kadam, Shilpa ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Acetylation; cAMP response element binding protein binding protein; Embryonic stem cell; p300; Sox2

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; LYSINE; TRANSCRIPTION FACTOR SOX2;

ACETYLATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; REDUCTION; UBIQUITINATION;

ACETYLATION; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CHROMATOGRAPHY, LIQUID; EMBRYONIC STEM CELLS; HOMEODOMAIN PROTEINS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; P300-CBP TRANSCRIPTION FACTORS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SOXB1 TRANSCRIPTION FACTORS; TANDEM MASS SPECTROMETRY;

EID: 70349871255     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.168     Document Type: Article

References (39)

1. Johnson BV, Rathjen J, Rathjen PD. Transcriptional control of pluripotency: Decisions in early development. Curr Opin Genet Dev 2006;16:447-454. (Pubitemid 44345209)
2. Boyer LA, Mathur D, Jaenisch R. Molecular control of pluripotency. Curr Opin Genet Dev 2006;16:455-462.
3. Wegner M. Secrets to a healthy Sox life: Lessons for melanocytes. Pigment Cell Res 2005;18:74-85. (Pubitemid 40445043)
4. Wilson M, Koopman P. Matching SOX: Partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 2002;12:441-446. (Pubitemid 34722924)
5. Wissmüller S, Kosian T, Wolf M et al. The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acid Res 2006;34:1735-1744.
6. Kuroda T, Tada M, Kubota H et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 2005;25:2475-2485. (Pubitemid 40354640)
7. Rodda DJ, Chew JL, Lim LH et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005;280:24731-24737.
8. Smith JM, Koopman PA. The ins and outs of transcriptional control: Nucleocytoplasmic shuttling in development and disease. Trends Genet 2004;20:4-8. (Pubitemid 38032815)
9. Wei F, Schöler HR, Atchison ML. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J Biol Chem 2007;282:21551-21560. (Pubitemid 47099909)
10. Tsuruzoe S, Ishihara K, Uchimura Y et al. Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem Biophys Res Commun 2006;351:920-926. (Pubitemid 44715874)
11. Brehm A, Ohbo K, Schöler H. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol Cell Biol 1997;17:154-162. (Pubitemid 26425604)
12. Saxe JP, Tomilin A, Schöler HR et al. Post-translational regulation of Oct4 transcriptional activity. PLoS One 2009;4:e4467.
13. Swaney DL, Wenger CD, Thomson JA et al. Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci U S A 2009;106:995-1000.
14. Yates A, Chambers I. The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells. Biochem Soc Trans 2005;33:1518-1521. (Pubitemid 41779728)
15. Gu W, Luo J, Brooks CL et al. Dynamics of the p53 acetylation pathway. Novartis Found Symp 2004;259:197-205.
16. Martínez-Balbás MA, Bauer UM, Nielsen SJ et al. Regulation of E2F1 activity by acetylation. EMBO J 2000;19:662-671.
17. Jeong JW, Bae MK, Ahn MY et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002;111:709-720.
18. Goodman RH, Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev 2000;14:1553-1577. (Pubitemid 30460905)
19. Chen X, Xu H, Yuan P et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008;133:1106-1117. (Pubitemid 351787745)
20. Bernadt CT, Nowling T, Rizzino A. Transcription factor Sox-2 inhibits co-activator stimulated transcription. Mol Reprod Dev 2004;69:260-267. (Pubitemid 39315007)
21. Nowling T, Bernadt C, Johnson L et al. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene. J Biol Chem 2003;278:13696-13705. (Pubitemid 36799905)
22. Nowling TK, Johnson LR, Wiebe MS et al. Identification of the transactivation domain of the transcription factor Sox-2 and an associated co-activator. J Biol Chem 2000;275:3810-3818.
23. Yaciuk P, Moran E. Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification. Mol Cell Biol 1991;11:5389-5397. (Pubitemid 21895303)
24. Rehberg S, Lischka P, Glaser G et al. Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol Cell Biol 2002;22:5826-5834. (Pubitemid 34815831)
25. Gasca S, Canizares J, De Santa Barbara P et al. A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination. Proc Natl Acad Sci U S A 2002;99:11199-11204. (Pubitemid 34920902)
26. Thevenet L, Méjean C, Moniot B et al. Regulation of human SRY subcellular distribution by its acetylation/deacetylation. EMBO J 2004;23:3336-3345. (Pubitemid 39209157)
27. Avilion AA, Nicolis SK, Pevny LH et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003;17:126-140.
28. Fornerod M, Ohno M, Yoshida M et al. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997;90:1051-1060. (Pubitemid 27408519)
29. Yang Y, Rao R, Shen J et al. Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res 2008;68:4833-4842.
30. Kopp JL, Ormsbee BD, Desler M et al. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008;26:903-911.
31. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49. (Pubitemid 46865811)
32. Masui S, Nakatake Y, Toyooka Y et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 2007;9:625-635. (Pubitemid 47214724)
33. Zhao LJ, Subramanian T, Zhou Y et al. Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. J Biol Chem 2006;281:4183-4189. (Pubitemid 43847846)
34. Huq MD, Wei LN. Post-translation modification of nuclear corepressor receptor-interacting protein 140 by acetylation. Mol Cell Proteomics 2005;4:975-983.
35. Sim H, Argentaro A, Harley VR. Boys, girls and shuttling of SRY and SOX9. Trends Endocrinol Metab 2008;19:213-222.
36. Yasuhara N, Shibazaki N, Tanaka S et al. Triggering neural differentiation of ES cells by subtype switching of importin-alpha. Nat Cell Biol 2007;9:72-79. (Pubitemid 46024199)
37. Li J, Pan G, Cui K et al. A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells. J Biol Chem 2007;282:19481-19492. (Pubitemid 47100100)
38. Baltus GA, Kowalski MP, Tutter AV et al. A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2. J Biol Chem 2009;284:6998-7006.
39. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-1489.